XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/bolder-reports-positive-results-phase-trial-bbt-015/20%Daily2018-04-30 23:00
https://www.clinicaltrialsarena.com/news/capricor-therapeutics-initiates-hope-2-trial-us/20%Daily2018-04-30 23:00
https://www.clinicaltrialsarena.com/news/conatus-completes-enrolment-encore-ph-trial/20%Daily2018-04-30 23:00
https://www.clinicaltrialsarena.com/news/ema-recommends-three-medicines-approval/20%Daily2018-04-30 13:26
https://www.clinicaltrialsarena.com/news/migraine-drug-prove-effective-nerve-agents/20%Daily2018-04-30 13:10
https://www.clinicaltrialsarena.com/comment/can-biomarker-guided-trial-resurrect-enzastaurin-non-hodgkins-lymphoma/20%Daily2018-04-30 11:13
https://www.clinicaltrialsarena.com/comment/endometriosis-focal-point-womens-health-innovation/20%Daily2019-08-09 08:36
https://www.clinicaltrialsarena.com/news/allergan-reports-positive-results-achieve-ii-trial/20%Daily2018-04-29 23:00
https://www.clinicaltrialsarena.com/news/corvus-start-enrolment-phase-ib-trial-cpi-006/20%Daily2018-04-29 23:00
https://www.clinicaltrialsarena.com/news/sutro-starts-dosing-phase-trial-stro-001/20%Daily2018-04-29 23:00
https://www.clinicaltrialsarena.com/news/ms-drug-treat-side-effects-cancer-treatment/20%Daily2018-04-27 12:30
https://www.clinicaltrialsarena.com/comment/facing-the-challenges-of-precision-medicine-and-biomarker-development-5789395-2/20%Daily2018-12-13 09:59
https://www.clinicaltrialsarena.com/news/durect-starts-dosing-phase-lla-trial-dur-928-ah/20%Daily2018-04-26 23:00
https://www.clinicaltrialsarena.com/news/deals-week-erydel-spa-cedilla-therapeutics-sangamo/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/vertex-begin-phase-lll-trials-vx-445-tezacaftor-ivacaftor/20%Daily2018-04-26 23:00
https://www.clinicaltrialsarena.com/news/alkahest-starts-phase-ll-trial-grf6019-alzheimers-disease/20%Daily2018-04-26 23:00
https://www.clinicaltrialsarena.com/news/new-transplant-protocol-allows-treatment-sickle-cell-disease/20%Daily2018-04-26 16:03
https://www.clinicaltrialsarena.com/news/researchers-create-gbm-tumour-models-cancer-studies/20%Daily2018-04-26 10:56
https://www.clinicaltrialsarena.com/comment/colorectal-cancer-pipeline-insight/20%Daily2018-04-26 09:24
https://www.clinicaltrialsarena.com/comment/patient-centric-clinical-trials-making-it-personal-6127125-2/20%Daily2018-12-13 10:01
https://www.clinicaltrialsarena.com/news/boston-doses-first-patients-two-trials-dsp-7888/20%Daily2018-04-25 23:00
https://www.clinicaltrialsarena.com/news/checkmate-begins-phase-1b-trial-cmp%e2%80%90001-atezolizumab/20%Daily2018-04-25 23:00
https://www.clinicaltrialsarena.com/news/tarveda-doses-first-patient-phase-iia-trial-pen-866/20%Daily2018-04-25 23:00
https://www.clinicaltrialsarena.com/news/novadigm-publishes-vulvovaginal-candidiasis-vaccine-study-results/20%Daily2018-04-25 16:20
https://www.clinicaltrialsarena.com/news/novartis-launches-app-off-site-trial-participation/20%Daily2018-04-25 16:17
https://www.clinicaltrialsarena.com/comment/oncology-ups-downs-enrollment-china/20%Daily2018-04-25 10:18
https://www.clinicaltrialsarena.com/news/world-malaria-day-drug-developers-work-towards-beating-malaria/20%Daily2018-04-25 09:58
https://www.clinicaltrialsarena.com/comment/clinical-operations-and-multi-regional-protocols-a-quest-for-quality-validation-of-value-6127121-2/20%Daily2018-12-13 10:02
https://www.clinicaltrialsarena.com/news/axsome-enrols-first-patient-phase-ii-trial-axs-05/20%Daily2018-04-24 23:00
https://www.clinicaltrialsarena.com/news/uthealth-receives-funding-phase-ii-trial-multistem/20%Daily2018-04-24 23:00
https://www.clinicaltrialsarena.com/news/epizyme-puts-enrolment-patients-tazemetostat-trials-hold/20%Daily2018-04-24 23:00
https://www.clinicaltrialsarena.com/comment/eccmid-2018-novel-rtss-malaria-vaccine-shows-encouraging-protection-early-stage-studies/20%Daily2018-04-24 15:20
https://www.clinicaltrialsarena.com/comment/male-contraceptive-pill-limits-sperm-activity-without-side-effects/20%Daily2019-08-09 08:41
https://www.clinicaltrialsarena.com/comment/immune-checkpoint-modulators-led-growth-immuno-oncology-trials-2008-2017/20%Daily2018-04-24 13:24
https://www.clinicaltrialsarena.com/news/moss-polysaccharide-potential-medical-uses/20%Daily2018-04-24 13:19
https://www.clinicaltrialsarena.com/comment/on-the-forefront-what-you-need-to-deliver-biomarker-data-6126577-2/20%Daily2018-12-13 10:04
https://www.clinicaltrialsarena.com/news/aobiome-starts-phase-ii-trial-aob-episodic-migraine/20%Daily2018-04-23 23:00
https://www.clinicaltrialsarena.com/news/lilly-reports-positive-top-line-results-range-trial/20%Daily2018-04-23 23:00
https://www.clinicaltrialsarena.com/news/zelda-completes-enrolment-new-trial-treat-insomnia/20%Daily2018-04-23 23:00
https://www.clinicaltrialsarena.com/comment/aacr-2018-mobilizing-innate-adaptive-immunity-simultaneously-overcome-anti-pd-1-therapy-resistant-melanoma/20%Daily2018-04-23 16:33
https://www.clinicaltrialsarena.com/comment/eccmid-2018-ribaxamase-demonstrates-protection-microbiome-following-ceftriaxone-treatment/20%Daily2018-04-23 16:30
https://www.clinicaltrialsarena.com/comment/eccmid-2018-avycaz-set-paediatric-label-expansion-following-phase-iib-trials/20%Daily2018-04-23 13:33
https://www.clinicaltrialsarena.com/comment/completed-thx-110-trial-marks-step-forward-medical-cannabis-development/20%Daily2018-04-23 11:09
https://www.clinicaltrialsarena.com/analysis/exploring-a-rescue-strategy-for-your-oncology-clinical-trial-6125058-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/announcing-oncology-week-on-clinical-trials-arena-6124893-2/20%Daily2018-12-13 10:07
https://www.clinicaltrialsarena.com/news/novadigm-initiates-phase-iia-trial-ndv-3a-s-aureus/20%Daily2018-04-22 23:00
https://www.clinicaltrialsarena.com/news/catalyst-pharmaceuticals-enrols-first-patient-msk-002-trial/20%Daily2018-04-22 23:00
https://www.clinicaltrialsarena.com/news/clementia-pharmaceuticals-starts-phase-ii-trial-palovarotene/20%Daily2018-04-22 23:00
https://www.clinicaltrialsarena.com/news/gene-edited-stem-cells-reduce-hiv-risk-non-human-primates/20%Daily2018-04-20 16:03
https://www.clinicaltrialsarena.com/news/compound-reduces-inflammation-stroke-patients/20%Daily2018-04-20 14:57
https://www.clinicaltrialsarena.com/comment/exploring-the-use-of-central-monitoring-in-rbm-studies-6123950-2/20%Daily2018-12-13 10:08
https://www.clinicaltrialsarena.com/news/gene-therapy-beta-thalassaemia-eliminate-need-transfusions/20%Daily2018-04-20 10:44
https://www.clinicaltrialsarena.com/news/synlogic-doses-first-subject-phase-iia-trial-synb1618/20%Daily2018-04-19 23:00
https://www.clinicaltrialsarena.com/news/summit-therapeutics-ends-dosing-phaseout-dmd-trial/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/deals-week-aeglea-biotherapeutics-bergenbio-evelo-biosciences/20%Daily2018-04-19 23:00
https://www.clinicaltrialsarena.com/news/qu-biologics-start-phase-ii-trial-qbeco-ssi-treat-cd/20%Daily2018-04-19 23:00
https://www.clinicaltrialsarena.com/news/low-cost-anti-hookworm-treatment-found-effective/20%Daily2018-04-19 16:19
https://www.clinicaltrialsarena.com/comment/aacr-2018-revisiting-murine-models-develop-drug-combos-kras-driven-cancers/20%Daily2018-04-19 15:50
https://www.clinicaltrialsarena.com/comment/aacr-2018-slfn11-predicts-response-parp-inhibition-small-cell-lung-cancer/20%Daily2018-04-19 15:38
https://www.clinicaltrialsarena.com/comment/taiwanjs-jkb-121-falls-victim-unexpected-placebo-response-nash-patients/20%Daily2018-04-19 15:27
https://www.clinicaltrialsarena.com/comment/ilc-2018-ngms-intravenous-nash-therapy-shows-rapid-reduction-liver-fat-content-fibrosis/20%Daily2018-04-19 15:23
https://www.clinicaltrialsarena.com/news/potential-drug-target-anti-obesity-treatment-discovered/20%Daily2018-04-19 14:52
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-effective-use-of-form-222-6122504-2/20%Daily2018-12-13 10:11
https://www.clinicaltrialsarena.com/news/16786/20%Daily2018-04-19 08:52
https://www.clinicaltrialsarena.com/news/merck-begin-two-phase-iii-trials-pcv-15-v114/20%Daily2018-04-18 23:00
https://www.clinicaltrialsarena.com/news/fervent-begins-phase-iia-trial-fp-101-vasomotor-symptoms/20%Daily2018-04-18 23:00
https://www.clinicaltrialsarena.com/news/asahi-starts-enrolment-phase-iii-trial-isavuconazole/20%Daily2018-04-18 23:00
https://www.clinicaltrialsarena.com/news/fda-approves-opdivo-yervoy-combo-treatment-kidney-cancer/20%Daily2018-04-18 14:17
https://www.clinicaltrialsarena.com/news/astrazeneca-announces-os-data-breast-cancer-treatment-lynparza/20%Daily2018-04-18 14:10
https://www.clinicaltrialsarena.com/comment/biopharmaceutical-manufacturing-success-strategies-with-contract-manufacturing-organizations-6120808-2/20%Daily2018-12-13 10:12
https://www.clinicaltrialsarena.com/comment/aacr-2018-dual-mechanism-cd40-agonists-support-anti-pd-l1-therapy-pancreatic-cancer/20%Daily2018-04-18 10:27
https://www.clinicaltrialsarena.com/news/idera-pharmaceuticals-conduct-three-trials-imo-2125/20%Daily2018-04-17 23:00
https://www.clinicaltrialsarena.com/news/glenmark-starts-phase-iib-trial-gbr-830/20%Daily2018-04-17 23:00
https://www.clinicaltrialsarena.com/news/novartis-reports-positive-outcome-liberty-trial/20%Daily2018-04-17 23:00
https://www.clinicaltrialsarena.com/comment/ilc-2018-madrigal-therapeutics-mcl-3196-reduces-liver-fat-nash-patients/20%Daily2018-04-17 17:09
https://www.clinicaltrialsarena.com/news/herantis-reports-positive-interim-data-gene-therapy-lymfactin/20%Daily2018-04-17 14:51
https://www.clinicaltrialsarena.com/comment/why-the-device-landscape-continues-to-face-significant-hurdles-6119076-2/20%Daily2018-12-13 10:13
https://www.clinicaltrialsarena.com/comment/ilc-2018-allergans-cenicriviroc-shows-continued-fibrosis-response-nash-patients-two-year-extended-study/20%Daily2018-04-17 09:25
https://www.clinicaltrialsarena.com/news/blueprint-medicines-reports-positive-data-arrow-trial/20%Daily2018-04-16 23:00
https://www.clinicaltrialsarena.com/news/beigene-doses-first-patient-phase-ii-trial-tislelizumab/20%Daily2018-04-16 23:00
https://www.clinicaltrialsarena.com/news/g1-therapeutics-starts-phase-ib-ii-trial-g1t38-tagrisso/20%Daily2018-04-16 23:00
https://www.clinicaltrialsarena.com/news/ketamine-nasal-spray-found-fast-acting-effect-depression/20%Daily2018-04-16 16:14
https://www.clinicaltrialsarena.com/news/algorithm-optimises-peptides-target-drug-resistant-bacteria/20%Daily2018-04-16 16:14
https://www.clinicaltrialsarena.com/news/astrazeneca-reports-post-progression-data-lung-cancer-drug-tagrisso/20%Daily2018-04-16 14:40
https://www.clinicaltrialsarena.com/news/ngm-bio-reports-positive-results-phase-ii-trial-ngm282/20%Daily2018-04-15 23:00
https://www.clinicaltrialsarena.com/news/canbridge-receives-approval-start-phase-ii-iii-trial-can008/20%Daily2018-04-15 23:00
https://www.clinicaltrialsarena.com/news/translate-bio-begin-phase-ii-trial-mrt5005/20%Daily2018-04-15 23:00
https://www.clinicaltrialsarena.com/news/positive-phase-data-rafael-leukaemia-combo-treatment/20%Daily2018-04-13 15:48
https://www.clinicaltrialsarena.com/news/generated-mouse-model-offers-possibility-personalised-cancer-treatment/20%Daily2018-04-13 14:22
https://www.clinicaltrialsarena.com/news/researchers-test-new-combo-treatment-therapy-resistant-melanoma/20%Daily2018-04-13 12:25
https://www.clinicaltrialsarena.com/news/affordable-hepatitis-c-treatment-shows-97-cure-rate/20%Daily2018-04-13 09:40
https://www.clinicaltrialsarena.com/comment/temperature-sensitive-challenges-in-last-mile-distribution-6114973-2/20%Daily2018-12-13 10:15
https://www.clinicaltrialsarena.com/news/deals-week-intec-pharma-fimecs-mereo-biopharma-group/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/treos-activates-new-site-mayo-clinic-polypepi-1018-trial/20%Daily2018-04-12 23:00
https://www.clinicaltrialsarena.com/news/new-trial-shows-positive-reports-personalised-tumour-vaccine/20%Daily2018-04-12 23:00
https://www.clinicaltrialsarena.com/news/pfizer-doses-first-patient-phase-ib-trial-pf-06939926/20%Daily2018-04-12 23:00
https://www.clinicaltrialsarena.com/news/aetion-raises-36m-develop-drug-efficacy-analysis-platform/20%Daily2018-04-12 13:27
https://www.clinicaltrialsarena.com/news/abbvie-arthritis-drug-outperforms-companys-best-seller-humira/20%Daily2018-04-12 12:58
https://www.clinicaltrialsarena.com/comment/4-things-to-consider-when-picking-the-right-site-5000101-2/20%Daily2018-12-13 10:16
https://www.clinicaltrialsarena.com/news/nektar-therapeutics-doses-first-patient-reveal-study/20%Daily2018-04-11 23:00
https://www.clinicaltrialsarena.com/news/oracle-develops-new-solution-digital-clinical-trials/20%Daily2018-04-11 23:00
https://www.clinicaltrialsarena.com/news/helix-receives-approval-begin-dosing-ldos003-trial/20%Daily2018-04-11 23:00
https://www.clinicaltrialsarena.com/news/scientists-reverse-damage-alzheimers-disease-human-brain-cells/20%Daily2018-04-11 15:16
https://www.clinicaltrialsarena.com/uncategorized/data-integrity-what-is-the-right-level-of-compliance-for-legacy-systems-6112402-2/20%Daily2018-12-13 10:17
https://www.clinicaltrialsarena.com/news/computer-simulation-offers-digital-penicillin-production/20%Daily2018-04-11 11:07
https://www.clinicaltrialsarena.com/news/abbvie-reports-positive-top-line-results-select-compare-trial/20%Daily2018-04-10 23:00
https://www.clinicaltrialsarena.com/news/pfizer-terminate-atlas-trial-renal-cell-carcinoma/20%Daily2018-04-10 23:00
https://www.clinicaltrialsarena.com/news/protalex-enrols-first-patient-cohort-four-prtx-100-202-study/20%Daily2018-04-10 23:00
https://www.clinicaltrialsarena.com/analysis/expert-insights-is-the-biopharma-industry-safe-from-the-us-china-trade-war-6110832-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/menlo-reports-negative-top-line-results-atomik-trial/20%Daily2018-04-09 23:00
https://www.clinicaltrialsarena.com/news/botanix-ends-enrolment-phase-ib-trial-btx-1204/20%Daily2018-04-09 23:00
https://www.clinicaltrialsarena.com/news/minnesota-u-m-partner-cancer-clinical-trials-network/20%Daily2018-04-09 23:00
https://www.clinicaltrialsarena.com/news/novartis-buy-avexis-inc-8-7bn-deal/20%Daily2018-04-09 14:47
https://www.clinicaltrialsarena.com/news/dalcor-increase-enrolment-dal-gene-trial-dalcetrapib/20%Daily2018-04-08 23:00
https://www.clinicaltrialsarena.com/news/feinstein-institute-start-new-trial-jbt-101-lupus/20%Daily2018-04-08 23:00
https://www.clinicaltrialsarena.com/news/incyte-merck-terminate-echo-301-keynote-252-study/20%Daily2018-04-08 23:00
https://www.clinicaltrialsarena.com/comment/universal-health-coverage-for-all-6107133-2/20%Daily2021-10-31 14:11
https://www.clinicaltrialsarena.com/news/uk-biobank-begin-full-genome-sequencing-participants/20%Daily2018-04-06 15:37
https://www.clinicaltrialsarena.com/comment/vaccine-development-need-speed/20%Daily2018-04-06 14:24
https://www.clinicaltrialsarena.com/news/liver-stem-cells-shown-regenerate-organ-mice/20%Daily2018-04-06 13:21
https://www.clinicaltrialsarena.com/news/drug-combination-provide-effective-lung-cancer-treatment/20%Daily2018-04-06 10:35
https://www.clinicaltrialsarena.com/news/ac-immune-announces-results-tau-candidates-alzheimers/20%Daily2018-04-06 08:58
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-how-to-prepare-for-fda-advisory-committee-meetings-6107033-2/20%Daily2018-12-13 11:30
https://www.clinicaltrialsarena.com/news/deals-week-biohaven-cellectis-antisense-therapeutics/20%Daily2018-04-05 23:00
https://www.clinicaltrialsarena.com/news/bioniz-starts-phase-ii-trial-bnz-1/20%Daily2018-04-05 23:00
https://www.clinicaltrialsarena.com/news/genoscience-begins-dosing-phase-iia-trial-gns561/20%Daily2018-04-05 23:00
https://www.clinicaltrialsarena.com/news/wize-pharma-ends-enrolment-phase-ii-trial-lo2a/20%Daily2018-04-05 23:00
https://www.clinicaltrialsarena.com/news/fda-grants-fast-track-designation-proteostasis-cf-therapy/20%Daily2018-04-05 14:24
https://www.clinicaltrialsarena.com/uncategorized/etmf-adoption-and-implementation-opportunity-to-reimagine-business-processes-6105149-2/20%Daily2018-12-13 11:33
https://www.clinicaltrialsarena.com/news/oryzon-secures-aemps-approval-initiate-etheral-trial/20%Daily2018-04-04 23:00
https://www.clinicaltrialsarena.com/news/first-patient-enrolled-adamas-phase-iii-trial-ads-5102/20%Daily2018-04-04 23:00
https://www.clinicaltrialsarena.com/news/retrophin-enrols-first-patient-duplex-study/20%Daily2018-04-04 23:00
https://www.clinicaltrialsarena.com/news/pfizer-allogene-partner-allogeneic-car-t-cell-therapies/20%Daily2018-04-04 16:20
https://www.clinicaltrialsarena.com/news/gut-microbiome-help-predict-efficacy-cancer-immunotherapies/20%Daily2018-04-04 15:11
https://www.clinicaltrialsarena.com/news/mechanism-bone-marrow-transplant-gvhd-discovered/20%Daily2018-04-04 10:48
https://www.clinicaltrialsarena.com/uncategorized/will-blockchain-deliver-on-its-promise-of-disrupting-the-life-sciences-6103638-2/20%Daily2018-12-13 11:35
https://www.clinicaltrialsarena.com/news/cocrystal-secures-fda-approval-start-phase-iia-trial-cc-31244/20%Daily2018-04-03 23:00
https://www.clinicaltrialsarena.com/news/first-patient-dosed-synlogics-phase-ib-iia-trial-synb1020/20%Daily2018-04-03 23:00
https://www.clinicaltrialsarena.com/news/strongbridge-doses-first-four-patients-logics-trial/20%Daily2018-04-03 23:00
https://www.clinicaltrialsarena.com/news/sanofi-seeks-ema-approval-asthma-drug-dupixent/20%Daily2018-04-03 15:50
https://www.clinicaltrialsarena.com/comment/oral-pill-treat-psoriasis-game-changer/20%Daily2018-04-03 11:41
https://www.clinicaltrialsarena.com/comment/glp-1-receptor-agonists-play-larger-role-binge-eating-disorder-treatment/20%Daily2018-04-03 11:33
https://www.clinicaltrialsarena.com/news/the-top-5-march-2018-6102009-2/20%Daily2018-12-13 11:36
https://www.clinicaltrialsarena.com/news/medicinova-end-phase-ii-trial-mn-001-nash-nafld/20%Daily2018-04-02 23:00
https://www.clinicaltrialsarena.com/news/myokardia-doses-first-patient-phase-ii-trial-mavacamten/20%Daily2018-04-02 23:00
https://www.clinicaltrialsarena.com/news/pfizer-reports-positive-topline-results-attr-act-study/20%Daily2018-04-02 23:00
https://www.clinicaltrialsarena.com/analysis/marchs-top-news-stories/20%Daily2018-04-01 23:00